Elliott Vichinsky, MD

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
ORCID ORCID Icon0000-0002-0500-9579 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Wisconsin, MadisonB.S. 1970Biology
    State University of New York DownstateM.D.1974School of Medicine
    Children's Orthopedic Hospital and Medical Center, Seattle, WAInternship1975Pediatrics
    Children's Orthopedic Hospital and Medical Center, Seattle, WAFellowship1978Pediatrics
    University of Washington, Seattle, WASenior Research Fellow1979Dept of Pediatrics and Medicine
    Collapse Awards and Honors
    Sickle Cell Disease Association of America (SCDAA)2013Pioneer Award
    Cooley's Anemia Foundation2009Distinguished Leadership as Chair of the Medical Advisory Board
    Sickle Cell Disease Foundation of California2007Lifetime Achievement Award
    Children's Hospital & Research Center Oakland2005Bronze Bambino Lifetime Achievement Award
    Children's Miracle Network1995Miracle Maker Award
    Alpha Omega Alpha Honor Society1974Alpha Omega Award
    State University of New York Downstate1974Cum Laude
    University of Wisconsin1970Cum Laude

    Collapse Overview 
    Collapse Overview
    I am the Director of Hematology/Oncology at UCSF Benioff Children's Hospital Oakland, Adjunct Professor at University of California San Francisco, as well as the Director of the Northern California Sickle Cell and Thalassemia Centers. I am a board-certified pediatric hematologist/oncologist with a major interest in understanding and improving the care of patients with hemoglobinopathies. My career has focused on translational research in hemoglobinopathies to answer therapeutic questions in hematologic and iron overload disorders, including iron metabolism and its consequences in multiple diseases, alloimmunization, transfusion efficacy and risks in hematology.

    Over 30 years ago, I established the hemoglobinopathy center at Children's Hospital Oakland to provide primary through tertiary care to pediatric and adult patients. I have been a federally-funded research investigator for over 30 years and national principal investigator for many successful trials -- including transfusion therapy and chelation therapy in hemoglobinopathies. I have been principal investigator or co-investigator on many of the key translational studies, including understanding the mechanism and treatment of neurologic injury in sickle cell disease; iron trafficking and iron overload in hemoglobinopathies, and new therapies to change the pathophysiology of sickle cell biology.

    I have served as Editor-in-Chief of Pediatric Hematology and Oncology; Chairman of the Thalassemia Clinical Research Network, and Director of the Cooley’s Medical Board.

    Collapse Research 
    Collapse Research Activities and Funding
    SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care
    NIH U01HL134007Aug 5, 2016 - Jun 30, 2022
    Role: Principal Investigator
    Phase 2 Study of Deferiprone in the Treatment of NBIA
    NIH R01FD004103Sep 15, 2012 - Aug 31, 2017
    Role: Principal Investigator
    Ninth Cooley's Anemia Symposium
    NIH R13HL096359Sep 1, 2009 - Aug 31, 2010
    Role: Principal Investigator
    Prevention of Complications in Thalassemia
    NIH U01DD000310Sep 30, 2007 - Mar 29, 2013
    Role: Principal Investigator
    Eighth Cooley's Anemia Symposium
    NIH R13HL079823Jan 1, 2005 - Dec 31, 2005
    Role: Principal Investigator
    Northern California Comprehensive Sickle Cell Centers
    NIH U54HL070583Jul 1, 2003 - Mar 31, 2010
    Role: Co-Investigator
    Modulation of Iron Deposition in SCD and Other Hemoglobinopathies
    NIH R01DK057778Aug 1, 2000 - Jun 30, 2013
    Role: Co-Principal Investigator
    Thalassemia Clinical Research Network
    NIH U01HL065239Jul 1, 2000 - Jun 30, 2011
    Role: Principal Investigator
    NIH R01HL061186Sep 30, 1998 - Jul 31, 2004
    Role: Principal Investigator
    NIH/NHLBI N01HB047107Apr 1, 1994 - Mar 31, 1999
    Role: Principal Investigator
    NIH/NHLBI N01HB097054Oct 1, 1988 - Sep 30, 1993
    Role: Principal Investigator
    NIH M01RR001271Dec 1, 1981 - Mar 31, 2007
    Role: Co-Investigator
    NIH P60HL020985Apr 1, 1978 - Mar 31, 2004
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Time to rethink haemoglobin threshold guidelines in sickle cell disease. Br J Haematol. 2021 Jun 15. Ballas SK, Kuypers FA, Gordeuk VR, Hankins JS, Thompson AA, Vichinsky E. PMID: 34131897.
      View in: PubMed   Mentions:    Fields:    
    2. Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia. Haematologica. 2021 06 01; 106(6):1740-1744. Singer ST, Fischer R, Allen I, Lal A, Vichinsky E, Yuan Q, Wang ZJ. PMID: 33121232.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. Bone Marrow Transplant. 2021 May 06. Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS. PMID: 33958740.
      View in: PubMed   Mentions:    Fields:    
    4. Survival and causes of death in 2033 patients with non-transfusion-dependent ß-thalassemia. Haematologica. 2021 Apr 22. Musallam KM, Vitrano A, Meloni A, Pollina WA, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A. PMID: 33882642.
      View in: PubMed   Mentions:    Fields:    
    5. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2021 May; 8(5):e323-e333. Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E. PMID: 33838113.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Voxelotor for the treatment of sickle cell disease. Expert Rev Hematol. 2021 Mar; 14(3):253-262. Vissa M, Vichinsky E. PMID: 33602029.
      View in: PubMed   Mentions:    Fields:    
    7. Iron Deficiency: Implications Before Anemia. Pediatr Rev. 2021 Jan; 42(1):11-20. Tong S, Vichinsky E. PMID: 33386301.
      View in: PubMed   Mentions: 1     Fields:    
    8. A complication risk score to evaluate clinical severity of thalassaemia syndromes. Br J Haematol. 2021 02; 192(3):626-633. Vitrano A, Meloni A, Addario Pollina W, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Titi Singer S, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Vichinsky E, Maggio A. PMID: 33216983.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Netw Open. 2020 07 01; 3(7):e2010874. Abrams DI, Couey P, Dixit N, Sagi V, Hagar W, Vichinsky E, Kelly ME, Connett JE, Gupta K. PMID: 32678452.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Influence of sickle cell disease on susceptibility to HIV infection. PLoS One. 2020; 15(4):e0218880. Kelly S, Jacobs ES, Stone M, Keating SM, Lee TH, Chafets D, Heitman J, Dimapasoc M, Operskalski E, Hagar W, Vichinsky E, Busch MP, Norris PJ, Custer B, Recipient Epidemiology and Donor Evaluation Study (REDS-III) . PMID: 32267841.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 09; 16(9):e17-e32. Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES. PMID: 31469310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol. 2019 07; 18(7):631-642. Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmiec T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E. PMID: 31202468.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    13. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519. Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J, HOPE Trial Investigators . PMID: 31199090.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCellsCTClinical Trials
    14. Vincristine-induced anemia in hereditary spherocytosis. Exp Biol Med (Maywood). 2019 07; 244(10):850-854. Michlitsch J, Larkin S, Vichinsky E, Kuypers FA. PMID: 31161774.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Evaluation of Mandible Fractures in Patients With Sickle Cell Anemia-A Nationwide Study. J Oral Maxillofac Surg. 2019 Jul; 77(7):1418-1422. Akbari M, Patel R, Carrao V, Hagar W, Vichinsky E, Chuang SK. PMID: 30707980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Transfusion practices and complications in thalassemia. Transfusion. 2018 12; 58(12):2826-2835. Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. PMID: 30260477.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    17. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease . PMID: 30021096.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    18. Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia. N Engl J Med. 2018 04 19; 378(16):1479-1493. Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M. PMID: 29669226.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCellsCTClinical Trials
    19. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States. Pediatr Blood Cancer. 2018 07; 65(7):e27067. Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, Cheng WY, McCormick N, Sasane M, Qiu Y, Kwiatkowski JL. PMID: 29637688.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. Hematol Oncol Clin North Am. 2018 04; 32(2):297-315. Carlberg KT, Singer ST, Vichinsky EP. PMID: 29458733.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Sickle cell disease. Nat Rev Dis Primers. 2018 03 15; 4:18010. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. PMID: 29542687.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansPHPublic Health
    22. Dietary nonheme iron is equally bioavailable from ferritin or ferrous sulfate in thalassemia intermedia. Pediatr Hematol Oncol. 2017 Nov; 34(8):455-467. Khurana M, Fung EB, Vichinsky EP, Theil EC. PMID: 29232169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):435-439. Vichinsky E. PMID: 29222290.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis. 2018 05; 70:66-77. Serjeant GR, Vichinsky E. PMID: 28689691.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    25. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience. Pediatr Hematol Oncol. 2017 Mar; 34(2):100-106. Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E. PMID: 28532265.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    26. Lifespan care in SCD: Whom to transition, the patients or the health care system? Am J Hematol. 2017 Jun; 92(6):487-489. Minniti CP, Vichinsky E. PMID: 28211097.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017 05; 177(4):620-629. Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. PMID: 28369718.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    28. Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST). Pediatr Blood Cancer. 2017 Sep; 64(9). Vichinsky E, El-Beshlawy A, Al Zoebie A, Kamdem A, Koussa S, Chotsampancharoen T, Bruederle A, Gilotti G, Han J, Elalfy M. PMID: 28296163.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease. PLoS One. 2017; 12(2):e0171067. Field JJ, Majerus E, Ataga KI, Vichinsky EP, Schaub R, Mashal R, Nathan DG. PMID: 28152086.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    30. Emergency department utilization by Californians with sickle cell disease, 2005-2014. Pediatr Blood Cancer. 2017 06; 64(6). Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. PMID: 28000344.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    31. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature. Prenat Diagn. 2016 Dec; 36(13):1242-1249. Kreger EM, Singer ST, Witt RG, Sweeters N, Lianoglou B, Lal A, Mackenzie TC, Vichinsky E. PMID: 27862048.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. Stroke recurrence in adult sickle cell patients: it is time for action! Transfusion. 2016 05; 56(5):1001-4. Neumayr L, Vichinsky E. PMID: 27167352.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016; 32(1):191-204. Vichinsky E. PMID: 26479125.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis. Am J Hematol. 2015 Sep; 90(9):E190-2. Singer ST, Killilea D, Suh JH, Wang ZJ, Yuan Q, Ivani K, Evans P, Vichinsky E, Fischer R, Smith JF. PMID: 26044409.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. Br J Haematol. 2015 Jun; 169(6):887-98. Morris CR, Kim HY, Klings ES, Wood J, Porter JB, Trachtenberg F, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Hassell K, Taher A, Neufeld EJ, Thompson AA, Larkin S, Suh JH, Vichinsky EP, Kuypers FA, Thalassemia Clinical Research Network . PMID: 25907665.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Is the medical home for adult patients with sickle cell disease a reality or an illusion? Hemoglobin. 2015; 39(2):130-3. Ballas SK, Vichinsky EP. PMID: 25806421.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    37. In utero hematopoietic cell transplantation for hemoglobinopathies. Front Pharmacol. 2014; 5:278. Derderian SC, Jeanty C, Walters MC, Vichinsky E, MacKenzie TC. PMID: 25628564.
      View in: PubMed   Mentions:
    38. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol. 2014 Dec; 167(5):692-6. Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E. PMID: 25209728.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    39. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014 Dec; 61(12):2271-6. Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB. PMID: 25176145.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    40. Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease. Hematology/Oncology Clinics of North America. 2014; 155-414. Vichinsky, Elliott P., ed. View Publication.
    41. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res. 2014 Oct; 23(8):2277-88. Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R, Thalassemia Clinical Research Network . PMID: 24682717.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol. 2014 Jul; 93(7):1139-48. Singer ST, Kuypers F, Fineman J, Gildengorin G, Larkin S, Sweeters N, Rosenfeld H, Kurio G, Higa A, Jeng M, Huang J, Vichinsky EP. PMID: 24577514.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group . PMID: 24523480.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18. Haematologica. 2014 Feb; 99(2):e19. Klings ES, Vichinsky EP, Morris CR. PMID: 24497564.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hematol Oncol Clin North Am. 2014 Apr; 28(2):xiii-xviii. Vichinsky EP. PMID: 24589274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014 Feb; 164(3):431-7. Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. PMID: 24180641.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Pain over time and its effects on life in thalassemia. Am J Hematol. 2013 Nov; 88(11):939-43. Oliveros O, Trachtenberg F, Haines D, Gerstenberger E, Martin M, Carson S, Green S, Calamaras D, Hess P, Yamashita R, Vichinsky E, Thalassemia Clinical Research Network . PMID: 23918696.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014 Mar; 61(3):567. Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. PMID: 24108577.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea. Am J Hematol. 2013 Dec; 88(12):1068-73. Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B, study CICL670A2201 investigators . PMID: 23946212.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    50. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2013 Oct; 98(4):960-71. Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. PMID: 23945720.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    51. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen. Am J Phys Med Rehabil. 2013 Aug; 92(8):728-33. Pratini NR, Sweeters N, Vichinsky E, Neufeld JA. PMID: 23370589.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr; 54(4):972-81; quiz 971. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA, CDC Thalassemia Investigators . PMID: 23889533.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    53. Pregnancy outcomes in women with thalassemia in North America and the United Kingdom. Am J Hematol. 2013 Sep; 88(9):771-3. Thompson AA, Kim HY, Singer ST, Vichinsky E, Eile J, Yamashita R, Giardina PJ, Olivieri N, Parmar N, Trachtenberg F, Neufeld EJ, Kwiatkowski JL, Thalassemia Clinical Research Network . PMID: 23757266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Non-transfusion-dependent thalassemias. Haematologica. 2013 Jun; 98(6):833-44. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. PMID: 23729725.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    55. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. J Cardiovasc Magn Reson. 2013 May 20; 15:38. Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, Giardina P, Thompson A, Moore B, Evans P, Kim HY, Macklin EA, Trachtenberg F. PMID: 23688265.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    56. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 2013 Sep; 98(9):1375-82. Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP. PMID: 23645695.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    57. Clinical manifestations of a-thalassemia. Cold Spring Harb Perspect Med. 2013 May 01; 3(5):a011742. Vichinsky EP. PMID: 23543077.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    58. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer. 2013 Sep; 60(9):1507-12. Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E. PMID: 23637051.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    59. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 2013 Sep; 98(9):1359-67. Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Singer ST, Taher A, Neufeld EJ, Thompson AA, Sachdev V, Larkin S, Suh JH, Kuypers FA, Vichinsky EP, Thalassemia Clinical Research Network . PMID: 23585527.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    60. Application of multiplex ligation-dependent probe amplification to screen for ß-globin cluster deletions: detection of two novel deletions in a multi ethnic population. Hemoglobin. 2013; 37(3):241-56. Cui J, Azimi M, Baysdorfer C, Vichinsky EP, Hoppe CC. PMID: 23577918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    61. Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients. AIDS Res Hum Retroviruses. 2013 Jul; 29(7):1006-9. Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W. PMID: 23409829.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol. 2013 Mar; 160(5):680-7. Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E, Thalassemia Clinical Research Network . PMID: 23278768.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    63. Increased leucocyte apoptosis in transfused ß-thalassaemia patients. Br J Haematol. 2013 Feb; 160(3):399-403. Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P, Thalassemia Clinical Research Network . PMID: 23216540.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    64. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis. 2013 Feb; 50(2):99-104. Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. PMID: 23151373.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    65. The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study. Am J Hematol. 2012 Oct; 87(10):E76-9. Fung EB, Gariepy CA, Sawyer AJ, Higa A, Vichinsky EP. PMID: 22886910.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    66. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2012 Nov; 87(11):1017-21. Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP. PMID: 22887019.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    67. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet. 2012 Jul; 112(7):980-90. Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP, Thalassemia Clinical Research Network . PMID: 22551675.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    68. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion. 2012 Dec; 52(12):2671-6. Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. PMID: 22519830.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    69. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012 May; 87(5):536-9. Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N, Embury SH. PMID: 22488107.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    70. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012 Apr; 26 Suppl 1:S31-4. Vichinsky E. PMID: 22631041.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    71. Identification of three novel Hb F variants: Hb F-Hayward [G?1(NA1)Gly?Asp, GGT>GAT], Hb F-Chori-I [A?T16(A13)Gly?Asp, GGC>GAC] and Hb F-Chori-II [A?I29(B11)Gly?Glu, GGA>GAA]. Hemoglobin. 2012; 36(3):305-9. Cui J, Baysdorfer C, Azimi M, Vichinsky EP, Hoppe CC. PMID: 22384921.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    72. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012 May 17; 119(20):4587-96. DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. PMID: 22354000.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    73. British Journal of Haematology. Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al. 2012; 157(4):506–507. Vichinsky E. . View Publication.
    74. Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood. 2012 Mar 22; 119(12):2746-53. Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ, Thalassemia Clinical Research Network . PMID: 22279056.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    75. Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine. Hematology Am Soc Hematol Educ Program. 2012; 2012:271-5. Vichinsky E. PMID: 23233591.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    76. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011 Oct; 134:522-31. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 22089616.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    77. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. Blood. 2011 Oct 06; 118(14):3794-802. Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP, Thalassemia Clinical Research Network . PMID: 21772051.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    78. Reproductive capacity in iron overloaded women with thalassemia major. Blood. 2011 Sep 08; 118(10):2878-81. Singer ST, Vichinsky EP, Gildengorin G, van Disseldorp J, Rosen M, Cedars MI. PMID: 21757620.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    79. A pilot study of subcutaneous decitabine in ß-thalassemia intermedia. Blood. 2011 Sep 08; 118(10):2708-11. Olivieri NF, Saunthararajah Y, Thayalasuthan V, Kwiatkowski J, Ware RE, Kuypers FA, Kim HY, Trachtenberg FL, Vichinsky EP, Thalassemia Clinical Research Network . PMID: 21700776.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    80. Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol. 2011 Aug; 154(3):387-97. Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T. PMID: 21592110.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    81. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol. 2011 May; 86(5):433-6. Trachtenberg F, Vichinsky E, Haines D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ, Thalassemia Clinical Research Network . PMID: 21523808.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    82. Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. Br J Haematol. 2011 Jul; 154(2):281-4. Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E. PMID: 21496003.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    83. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol. 2011 Jun; 153(5):655-63. Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L. PMID: 21477202.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    84. Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover. Bone. 2011 Jun 01; 48(6):1305-12. Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, Zemel BS. PMID: 21443975.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    85. The mediating effects of family functioning on psychosocial outcomes in healthy siblings of children with sickle cell disease. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1055-61. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 21360652.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    86. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011 Feb 24; 364(8):710-8. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. PMID: 21345100.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    87. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011 Apr; 153(1):121-8. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski JL, Thalassemia Clinical Research Network Investigators . PMID: 21323889.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    88. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. British Journal of Haematology. 2011; 152(6):771–776. Wang, W., Brugnara, C., Snyder, C., Wynn, L., Rogers, Z., Kalinyak, K., Brown, C., Qureshi, A., Bigelow, C., Neumayr, L., Smith-Whitley, K., Chui, D. H. K., Delahunty, M., Woolson, R., Steinberg, M., Telen, M. and Kesler, K. View Publication.
    89. Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease. Pediatr Blood Cancer. 2011 Jan; 56(1):95-8. Jacobs JE, Quirolo K, Vichinsky E. PMID: 20973097.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    90. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload. Haematologica. 2011 Apr; 96(4):521-5. Rienhoff HY, Viprakasit V, Tay L, Harmatz P, Vichinsky E, Chirnomas D, Kwiatkowski JL, Tapper A, Kramer W, Porter JB, Neufeld EJ. PMID: 21173101.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    91. HbE/ß-thalassemia: basis of marked clinical diversity. Hematol Oncol Clin North Am. 2010 Dec; 24(6):1055-70. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 21075280.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    92. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010 Nov; 102(11):1017-23. Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ. PMID: 21141289.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. Education and employment status of children and adults with thalassemia in North America. Pediatr Blood Cancer. 2010 Oct; 55(4):678-83. Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky E. PMID: 20535817.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Pulmonary hypertension and NO in sickle cell. Blood. 2010 Aug 05; 116(5):852-4. Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP. PMID: 20688967.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    95. Preface to Cooley's Anemia: Ninth Symposium. Ann N Y Acad Sci. 2010 Aug; 1202:ix-x. Vichinsky EP, Neufeld EJ. PMID: 20712763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2010 Aug; 1202:205-13. Morris CR, Vichinsky EP. PMID: 20712794.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    97. Fertility potential in thalassemia major women: current findings and future diagnostic tools. Ann N Y Acad Sci. 2010 Aug; 1202:226-30. Singer ST, Sweeters N, Vega O, Higa A, Vichinsky E, Cedars M. PMID: 20712797.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    98. Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann N Y Acad Sci. 2010 Aug; 1202:180-7. Vichinsky E. PMID: 20712791.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    99. Transfusion and chelation practices in sickle cell disease: a regional perspective. Pediatr Hematol Oncol. 2011 Mar; 28(2):124-33. Vichinsky EP, Ohene-Frempong K, Thein SL, Lobo CL, Inati A, Thompson AA, Smith-Whitley K, Kwiatkowski JL, Swerdlow PS, Porter JB, Marks PW. PMID: 20673030.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    100. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey. Pediatr Hematol Oncol. 2011 Feb; 28(1):37-42. Vichinsky EP, Ohene-Frempong K, Transfusion Committee . PMID: 20673029.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    101. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia. J Pediatr. 2010 Oct; 157(4):641-7, 647.e1-2. Fung EB, Xu Y, Kwiatkowski JL, Vogiatzi MG, Neufeld E, Olivieri N, Vichinsky EP, Giardina PJ, Thalassemia Clinical Research Network . PMID: 20547400.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    102. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010 May 12; 303(18):1823-31. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group . PMID: 20460621.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    103. Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol. 2010 Mar; 27(2):112-21. James EB, Vreman HJ, Wong RJ, Stevenson DK, Vichinsky E, Schumacher L, Hall JY, Simon J, Golden DW, Harmatz P. PMID: 20201692.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    104. Pulmonary hypertension in hemolytic anemias. F1000 Med Rep. 2010 Feb 11; 2. Wahl S, Vichinsky E. PMID: 20948876.
      View in: PubMed   Mentions:
    105. Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging. 2010 Apr; 28(3):363-71. Wang ZJ, Fischer R, Chu Z, Mahoney DH, Mueller BU, Muthupillai R, James EB, Krishnamurthy R, Chung T, Padua E, Vichinsky E, Harmatz P. PMID: 20061110.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    106. Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease. Pediatr Blood Cancer. 2010 Jan; 54(1):148-50. Gabrovsky A, Aderinto A, Aderinto A, Spevak M, Vichinsky E, Resar LM. PMID: 19785026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. Iron metabolism and iron chelation in sickle cell disease. Acta Haematol. 2009; 122(2-3):174-83. Walter PB, Harmatz P, Vichinsky E. PMID: 19907155.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    108. Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications. Am J Hematol. 2009 Nov; 84(11):759-61. Singer ST, Kim HY, Olivieri NF, Kwiatkowski JL, Coates TD, Carson S, Neufeld E, Cunningham MJ, Giardina PJ, Mueller BU, Quinn CT, Fung E, Vichinsky E, Thalassemia Clinical Research Network . PMID: 19787795.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    109. Severe sickle cell disease--pathophysiology and therapy. Biol Blood Marrow Transplant. 2010 Jan; 16(1 Suppl):S64-7. Buchanan G, Vichinsky E, Krishnamurti L, Shenoy S. PMID: 19819341.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    110. Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. Br J Haematol. 2009 Dec; 147(5):752-9. Taher A, Cappellini MD, Vichinsky E, Galanello R, Piga A, Lawniczek T, Clark J, Habr D, Porter JB. PMID: 19764988.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    111. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8. Adamkiewicz TV, Abboud MR, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, Casella JF, Alvarez OA, Barredo JC, Lee MT, Iyer RV, Kutlar A, McKie KM, McKie V, Odo N, Gee B, Kwiatkowski JL, Woods GM, Coates T, Wang W, Adams RJ. PMID: 19721013.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    112. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009 Sep; 146(5):546-56. Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Fleisher M, Grady RW, Peterson CM, Giardina PJ, Thalassemia Clinical Research Network . PMID: 19604241.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    113. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol. 2009 Jul; 84(7):462-4. Hoppe C, Klitz W, Vichinsky E, Styles L. PMID: 19484735.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    114. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009 Apr; 52(4):486-90. Michlitsch J, Azimi M, Hoppe C, Walters MC, Lubin B, Lorey F, Vichinsky E. PMID: 19061217.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    115. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009 Mar; 24(3):543-57. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ, Thalassemia Clinical Research Network . PMID: 18505376.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    116. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009; 35-41. Vichinsky EP. PMID: 20008180.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    117. Pulmonary complications of sickle cell disease. N Engl J Med. 2008 Nov 20; 359(21):2254-65. Gladwin MT, Vichinsky E. PMID: 19020327.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    118. Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol. 2008 Nov; 83(11):842-5. Singer ST, Vichinsky EP, Larkin S, Olivieri N, Sweeters N, Kuypers FA, E/beta Thalassemia Study Group . PMID: 18821710.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Hemoglobinopathies. Curr Mol Med. 2008 Nov; 8(7):591. Vichinsky E, Rodgers GP, Rachmilewitz E. PMID: 18991644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Psychosocial and behavioral outcomes in children with sickle cell disease and their healthy siblings. J Behav Med. 2008 Dec; 31(6):506-16. Gold JI, Mahrer NE, Treadwell M, Weissman L, Vichinsky E. PMID: 18784995.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    121. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica. 2008 Aug; 93(8):1247-51. Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N, Thalassemia Clinical Research Network . PMID: 18556414.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    122. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008 Jun; 25(5):409-21. Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. PMID: 18569843.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    123. Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia. Pediatrics. 2008 Jun; 121(6):1253-6. Vichinsky E. PMID: 18519495.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    124. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 2008 Sep; 48(9):1971-80. Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP, Multi-Center Iron Overload Research Group . PMID: 18513257.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    125. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008 Jun; 93(6):817-25. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Vichinsky E, Olivieri N, Alberti D, Holland J, Harmatz P, Thalassemia Clinical Research Network . PMID: 18469351.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    126. Clinical application of deferasirox: practical patient management. Am J Hematol. 2008 May; 83(5):398-402. Vichinsky E. PMID: 18058997.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    127. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol. 2008; 119(3):133-41. Vichinsky E, Pakbaz Z, Onyekwere O, Porter J, Swerdlow P, Coates T, Lane P, Files B, Mueller BU, Coïc L, Forni GL, Fischer R, Marks P, Rofail D, Abetz L, Baladi JF. PMID: 18408362.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    128. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone. 2008 Jul; 43(1):162-168. Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP, Multi-Center Iron Overload Study Group . PMID: 18430624.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    129. Advances in clinical research in sickle cell disease. Br J Haematol. 2008 May; 141(3):346-56. Hagar W, Vichinsky E. PMID: 18341629.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    130. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer. 2008 Feb; 50(2):319-24. Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC. PMID: 17557314.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    131. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008 Apr 15; 111(8):3991-7. Ataga KI, Smith WR, De Castro LM, Swerdlow P, Saunthararajah Y, Castro O, Vichinsky E, Kutlar A, Orringer EP, Rigdon GC, Stocker JW, ICA-17043-05 Investigators . PMID: 18192510.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    132. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]. Hemoglobin. 2008; 32(6):601-7. Porter JB, Taher AT, Cappellini MD, Vichinsky EP. PMID: 19065340.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    133. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol. 2008 Feb; 80(2):168-76. Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD, Olivieri N, Piga A, Cunningham MJ, Soulières D, Gattermann N, Tchernia G, Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C. PMID: 18028431.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    134. Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br J Haematol. 2008 Jan; 140(1):104-12. Hagar RW, Michlitsch JG, Gardner J, Vichinsky EP, Morris CR. PMID: 17916102.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    135. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008 Jan 01; 111(1):402-10. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES. PMID: 17848621.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    136. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007 Sep; 49(3):329-32. Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. PMID: 17554789.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    137. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Br J Haematol. 2007 Aug; 138(3):374-81. Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B. PMID: 17614825.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    138. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol. 2007 Jun; 24(4):237-43. Jenkins ZA, Hagar W, Bowlus CL, Johansson HE, Harmatz P, Vichinsky EP, Theil EC. PMID: 17613866.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    139. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther. 2007 May; 29(5):909-917. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. PMID: 17697909.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    140. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol. 2007 Apr; 82(4):255-65. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group . PMID: 17094096.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    141. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007 Feb; 136(3):501-8. Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T, Deferasirox in Sickle Cell Investigators . PMID: 17233848.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    142. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer. 2007 Jan; 48(1):64-71. Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, Wrubel J, Wilson L, Folkman S. PMID: 16622841.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    143. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program. 2007; 79-83. Vichinsky E. PMID: 18024613.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    144. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006 Dec; 88(12):2573-82. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP, National Osteonecrosis Trial in Sickle Cell Anemia Study Group . PMID: 17142406.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    145. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006 Dec; 47(7):901-6. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. PMID: 16317761.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    146. Dose-escalation study of ICA-17043 in patients with sickle cell disease. Pharmacotherapy. 2006 Nov; 26(11):1557-64. Ataga KI, Orringer EP, Styles L, Vichinsky EP, Swerdlow P, Davis GA, Desimone PA, Stocker JW. PMID: 17064199.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    147. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006 Nov; 135(4):574-82. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP, Multi-Centre Study of Iron Overload Research Group . PMID: 17054676.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    148. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006 Oct; 135(2):254-63. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. PMID: 17010049.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    149. Prevalence of HFE mutations in California newborns. Pediatr Hematol Oncol. 2006 Sep; 23(6):507-16. Hoppe C, Watson RM, Long CM, Lorey F, Robles L, Klitz W, Styles L, Vichinsky E. PMID: 16849282.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    150. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006 Sep; 81(9):670-5. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. PMID: 16795058.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    151. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc. 2006 May; 98(5):704-10. Treadwell MJ, McClough L, Vichinsky E. PMID: 16749645.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    152. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005 Dec; 116(6):e818-25. Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. PMID: 16291734.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    153. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005 Nov; 131(3):378-88. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP, E/beta Thalassaemia Study Group . PMID: 16225658.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    154. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct; 19(5):929-41, viii. Aguilar C, Vichinsky E, Neumayr L. PMID: 16214653.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    155. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005 Sep; 80(1):70-4. Vichinsky E, Butensky E, Fung E, Hudes M, Theil E, Ferrell L, Williams R, Louie L, Lee PD, Harmatz P. PMID: 16138345.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    156. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005 Jul 06; 294(1):81-90. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT. PMID: 15998894.
      View in: PubMed   Mentions: 234     Fields:    Translation:Humans
    157. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score. Arch Phys Med Rehabil. 2005 Jul; 86(7):1369-75. Aguilar CM, Neumayr LD, Eggleston BE, Earles AN, Robertson SM, Jergesen HE, Stulberg BN, Vichinsky EP. PMID: 16003666.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    158. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005 May; 44(5):500-7. Treadwell MJ, Law AW, Sung J, Hackney-Stephens E, Quirolo K, Murray E, Glendenning GA, Vichinsky E. PMID: 15602707.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    159. Treatment of hepatitis C virus infection in thalassemia. Ann N Y Acad Sci. 2005; 1054:290-9. Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P. PMID: 16339677.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    160. Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:439-44. Offer T, Bhagat A, Lal A, Atamna W, Singer ST, Vichinsky EP, Kuypers FA, Ames BN. PMID: 16339694.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    161. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005; 1054:457-61. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. PMID: 16339697.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    162. Utility of Holter electrocardiogram in iron-overloaded hemoglobinopathies. Ann N Y Acad Sci. 2005; 1054:476-80. Qureshi N, Avasarala K, Foote D, Vichinsky EP. PMID: 16339701.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    163. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005; 1054:481-5. Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, Vichinsky EP. PMID: 16339702.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    164. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: A retrospective analysis. Ann N Y Acad Sci. 2005; 1054:500-3. Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP. PMID: 16339706.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    165. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. PMID: 15762291.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    166. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005; 1054:18-24. Vichinsky EP. PMID: 16339647.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    167. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group. Ann N Y Acad Sci. 2005; 1054:33-9. Premawardhena A, De Silver S, Arambepola M, Olivieri NF, Vichinsky EP, Merson L, Muraco G, Allen A, Fisher C, Peto T, Weatherall DJ. PMID: 16339649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    168. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci. 2005; 1054:250-6. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP. PMID: 16339672.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    169. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:486-91. Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP. PMID: 16339703.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    170. Hematologic problems in immigrants from Southeast Asia. Hematol Oncol Clin North Am. 2004 Dec; 18(6):1405-22, x. Jeng MR, Vichinsky E. PMID: 15511622.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    171. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72. Jones A, Granger S, Brambilla D, Gallagher D, Vichinsky E, Woods G, Berman B, Roach S, Nichols F, Adams RJ. PMID: 15517239.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    172. Thalassemia in Sri Lanka: a progress report. Hum Mol Genet. 2004 Oct 01; 13 Spec No 2:R203-6. Premawardhena A, De Silva S, Arambepola M, Olivieri N, Merson L, Muraco J, Allen A, Fisher C, Peto T, Vichinsky E, Weatherall D. PMID: 15358726.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    173. The role of fetal hemoglobin-enhancing agents in thalassemia. Semin Hematol. 2004 Oct; 41(4 Suppl 6):17-22. Lal A, Vichinsky E. PMID: 15534853.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    174. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004 Feb 26; 350(9):857-9. Vichinsky EP. PMID: 14985481.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    175. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94. Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, Pegelow CH, Woods G, Rohde EM, Nichols FT, Jones A, Luden JP, Bowman L, Hagner S, Morales KH, Roach ES, STOP Study . PMID: 14751925.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    176. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004; 14-34. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. PMID: 15561674.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    177. Managing sickle cell disease. BMJ. 2003 Nov 15; 327(7424):1151-5. Claster S, Vichinsky EP. PMID: 14615343.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    178. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004 Mar 15; 103(6):2391-6. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L, CSSCD Investigators . PMID: 14615367.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    179. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003 Oct; 143(4):438-44. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, Van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC. PMID: 14571216.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    180. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol. 2003 Aug; 25(8):629-34. Morris CR, Vichinsky EP, van Warmerdam J, Machado L, Kepka-Lenhart D, Morris SM, Kuypers FA. PMID: 12902916.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    181. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003 Jul; 112(1 Pt 1):87-95. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, Grossi M, Grover R, McMahon L, Swerdlow P, Waldron P, Vichinsky E. PMID: 12837872.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    182. Deferiprone and hepatic fibrosis. Blood. 2003 Jun 15; 101(12):5089-90; author reply 5090-1. Brittenham GM, Nathan DG, Olivieri NF, Porter JB, Pippard M, Vichinsky EP, Weatherall DJ. PMID: 12788794.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    183. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003 Apr 02; 289(13):1645-51. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. PMID: 12672732.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansCTClinical Trials
    184. Liver ferritin subunit ratios in neonatal hemochromatosis. Pediatr Hematol Oncol. 2003 Apr-May; 20(3):229-35. Hagar W, Vichinsky EP, Theil EC. PMID: 12637219.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    185. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med. 2003 Jul 01; 168(1):63-9. Morris CR, Morris SM, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. PMID: 12626350.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    186. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol. 2003 Jan; 25(1):46-55. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, Iyer RV, Ware RE, Koshy M, Rackoff WR, Pegelow CH, Waldron P, Benjamin L, Vichinsky E, Acute Chest Syndrome Study Group . PMID: 12544773.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    187. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003 Apr 01; 101(7):2865-9. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, Styles L. PMID: 12517810.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    188. Pancytopenia induced by hypothermia. J Pediatr Hematol Oncol. 2002 Nov; 24(8):681-4. Lo L, Singer ST, Vichinsky E. PMID: 12439045.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    189. Diseases of iron metabolism. Pediatr Clin North Am. 2002 Oct; 49(5):893-909. Hagar W, Theil EC, Vichinsky EP. PMID: 12430618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    190. New therapies in sickle cell disease. Lancet. 2002 Aug 24; 360(9333):629-31. Vichinsky E. PMID: 12241949.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    191. Bioelectrical impedance analysis of the body composition of children and adolescents with sickle cell disease. J Pediatr. 2002 Jun; 140(6):681-7. VanderJagt DJ, Harmatz P, Scott-Emuakpor AB, Vichinsky E, Glew RH. PMID: 12072870.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    192. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol. 2002 May; 24(4):284-90. Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, Granger S, Adams RJ. PMID: 11972097.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    193. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002 Apr 15; 99(8):3014-8. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, Kinney TR. PMID: 11929794.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    194. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002 Feb; 69(2):103-8. Jeng MR, Feusner J, Skibola C, Vichinsky E. PMID: 11835345.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    195. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage. 2002 Feb; 23(2):114-20. Franck LS, Treadwell M, Jacob E, Vichinsky E. PMID: 11844631.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    196. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 2002 Feb; 140(2):225-9. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR. PMID: 11865275.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    197. Using quality improvement strategies to enhance pediatric pain assessment. Int J Qual Health Care. 2002 Feb; 14(1):39-47. Treadwell MJ, Franck LS, Vichinsky E. PMID: 11871628.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    198. Novel therapeutic approaches in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2002; 10-34. Walters MC, Nienhuis AW, Vichinsky E. PMID: 12446417.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    199. Preparation and properties of a cell-free system from rat skin that catalyzes sterol biosynthesis. J Lipid Res. 1966 Jul; 7(4):501-10. Gaylor JL, Delwiche CV, Brady DR, Green AJ. PMID: 4290536.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    200. Guidelines for the Management of Non Tranfusion Dependent Thalassemia (NTDT). Thalassemia International Federation, 2013. Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. View Publication.
    Elliott's Networks
    Concepts (718)
    Derived automatically from this person's publications.
    Co-Authors (45)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department